Here are the top health news for the day:
New pharma code implements stricter regulations on sample distribution to doctors
Pharma companies and Medical Representatives (MRs) can only distribute sample packs that strictly adhere to the prescribed dosage for a maximum of three patients during the requisite treatment period, the recent pharma code issued by the government has stated. Furthermore, no pharma company is permitted to offer more than twelve sample packs per drug to any healthcare practitioner within a single year, the Government notified in its newly introduced Uniform Code for Pharmaceutical Marketing Practices (UCPMP) 2024.
The Ministry of Chemicals and Fertilizers, Department of Pharmaceuticals, in an endeavor to encourage ethical conduct and transparency within the pharmaceutical industry, has come up with the Uniform Code for Pharmaceutical Marketing Practices (UCPMP) 2024. The UCPMP 2024, introduced on March 12th 2024, aims to overhaul existing marketing practices by imposing strict guidelines on pharmaceutical companies and healthcare practitioners.
For more information, click on the link below:
The authority's order alleges that Dr. Reddy's wrongly availed input tax credit or failed to reverse it under the provisions of the CGST/TGST/IGST Act, 2017. The tax amount in question is Rs 67,47,37,495, with interest to be calculated at applicable rates on the tax demand. The penalty amounts to Rs 6,74,73,752.
The concerned institutes have been notified of the communications through email IDs for taking necessary action within the stipulated timeline. Among these 214 applications, 160 applications are for starting new PG medical courses and the rest of the 54 applications are for increase of PG medical seats.
The study revealed that life expectancy declined in 84% of countries and territories during this period, highlighting the devastating potential impacts of novel pathogens. Particularly hard-hit areas included Mexico City, Peru, and Bolivia. While adult mortality rates surged globally during the pandemic, child mortality continued to decrease, albeit at a slower pace than previous years. The research, part of the Global Burden of Disease Study 2021, underscores the urgency for stakeholders to understand and address the ongoing changes in global health landscapes, both due to the pandemic and long-term trends.
Reference: Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021, the Lancet, DOI:https://doi.org/10.1016/S0140-6736(24)00476-8
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd